1. Home
  2. ATCH vs MDXH Comparison

ATCH vs MDXH Comparison

Compare ATCH & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.21

Market Cap

34.5M

Sector

N/A

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.57

Market Cap

41.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATCH
MDXH
Founded
2022
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
34.5M
41.1M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
ATCH
MDXH
Price
$0.21
$0.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$1.00
$7.67
AVG Volume (30 Days)
1.5M
1.3M
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
N/A
N/A
Revenue This Year
$84.47
$30.78
Revenue Next Year
$39.32
$18.31
P/E Ratio
$4.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.51
52 Week High
$1.92
$5.33

Technical Indicators

Market Signals
Indicator
ATCH
MDXH
Relative Strength Index (RSI) 39.35 14.37
Support Level $0.21 $0.51
Resistance Level $0.24 $3.78
Average True Range (ATR) 0.02 0.08
MACD -0.00 0.02
Stochastic Oscillator 50.35 15.49

Price Performance

Historical Comparison
ATCH
MDXH

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: